Scott+Scott, Attorneys at Law, LLP Announces Investigation of Sarepta Therapeutics, Inc.
March 28, 2017 11:41 ET | Scott + Scott, Attorneys at Law, LLP
NEW YORK, March 28, 2017 (GLOBE NEWSWIRE) -- Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, announces an investigation into Sarepta...
Race to Yes Underscores Evidence Presented at FDA Advisory Committee Meeting for Duchenne Muscular Dystrophy Drug Eteplirsen
April 27, 2016 13:38 ET | The Race to Yes
Organization Urges FDA to Use the Evidence Presented by Dozens of Scientists, Physicians, Patients and Advocates as Required by 2012 FDASIA Act for Conditional Approval Experts Remind Duchenne...